Raymond James Downgrades Dialysis Corp. of America (DCAI) to Market Perform
DCAI Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Raymond James downgrades Dialysis Corp. of America (Nasdaq: DCAI) from Strong Buy to Market Perform.
Shares of Dialysis Corp. are down more than 5% today following Q1 results reported yesterday after the closing bell rang. The stock most recently traded at $4.90.
Click here to see all the analyst upgrades/downgrades specifically for Dialysis Corp.
Dialysis Corporation of America, through its subsidiaries, develops, owns, and operates outpatient kidney dialysis centers in the United States and internationally.
Shares of Dialysis Corp. are down more than 5% today following Q1 results reported yesterday after the closing bell rang. The stock most recently traded at $4.90.
Click here to see all the analyst upgrades/downgrades specifically for Dialysis Corp.
Dialysis Corporation of America, through its subsidiaries, develops, owns, and operates outpatient kidney dialysis centers in the United States and internationally.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Canaccord Genuity Maintains a 'Hold' on Tiffany & Co. (TIF); Cutting PT and Estimates
- Needham & Company Reiterates a 'Buy' on UQM Technologies (UQM); Increasing EV Adoption
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
